DS5361b Clinical Trials (2026): 1 Studies for Advanced Solid Tumor
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 DS5361b clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Advanced Solid Tumor) and 192 total planned enrollment. 1 DS5361b clinical trial is actively recruiting at 5 U.S. sites across 4 states. Most recent activity: NCT07182591 (Dec 2030).
Where to Participate: All DS5361b Trial Sites in the U.S. (5 sites across 4 states)
Every actively recruiting DS5361btrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| FL | Research Site | Sarasota34232 | NCT07182591 | Map |
| RI | Research Site | Providence02903 | NCT07182591 | Map |
| TX | Research Site | Irving75039 | NCT07182591 | Map |
| TX | Research Site | San Antonio78229 | NCT07182591 | Map |
| VA | Research Site | Fairfax22031 | NCT07182591 | Map |
DS5361b clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting DS5361b clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07182591 | A Study of DS5361b in Participants With Advanced Solid Tumors | P1 | Advanced Solid Tumor | 192 | Oct 2025 |
All DS5361b trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07182591 | A Study of DS5361b in Participants With Advanced Solid Tumors | P1 | recruiting | 192 | Daiichi Sankyo | Oct 2025 |
DS5361b clinical trials: frequently asked questions
- How many DS5361b clinical trials are there?
- 1 DS5361b clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are DS5361b clinical trials recruiting in 2026?
- Yes — 1 DS5361b trial is actively recruiting in 2026, with 5 U.S. sites across 4 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is DS5361b being studied for?
- DS5361b is being studied for Advanced Solid Tumor. The trials are grouped by indication on this page.
- What phase is DS5361b in?
- DS5361b clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors DS5361b clinical trials?
- The lead sponsor across the most DS5361b trials is Daiichi Sankyo. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming DS5361bas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: